Chairman of the Board and CEO Hong Zhi increased his holdings of Tengsheng Pharmaceutical-B (02137) by 205,000 shares at a price of approximately HK$1 per share

Zhitongcaijing · 11/26 10:57

The Zhitong Finance App learned that according to the latest data from the Hong Kong Stock Exchange, Hong Zhi, Chairman of the Board of Directors and CEO, increased his holdings of Tengsheng Pharmaceutical-B (02137) by 205,000 shares, at a price of HK$1.0007 per share, for a total amount of about HK$205,000. After the increase in holdings, the latest number of shares held was approximately 41.0748 million shares, and the latest shareholding ratio was 5.62%.

image.png